We found that DM patient-derived EMPs significantly induced IL-1b and TNF-a mRNA expression, whereas they inhibited IL-10 mRNA expression compared to healthy volunteer-derived EMPs (Figure 2B), which indicated that DM patient-derived EMPs increased inflammatory release in cultured ECs. The gene discussed is TNF; the disease is diabetes mellitus.